Louis Hand, professor emeritus of physics, who dedicated more than 40 years to the Cornell community as a professor in the Department of Physics, in the College of Arts and Sciences, died Oct. 30. He was 90.
Osei Boateng ’18, MHA ’20, founder of OKB Hope Foundation, a nonprofit dedicated to transforming health care delivery in Africa, is the latest guest on the Startup Cornell podcast.
In this episode of the Inclusive Excellence Podcast, two Gen Xs, a Baby Boomer and a Millennial dive into today’s multigenerational workforce and discuss the challenges and opportunities it presents
Steps from where dozens of young immigrant Jewish and Italian women died when a fire erupted in the locked sweatshop, 60 Cornell students, faculty, staff and alumni gathered Oct. 11 to honor the legacy of the Triangle Shirtwaist Factory tragedy.
Seventeen individuals and three teams of Cornell employees received President's Awards for Employee Excellence in seven categories, highlighting the achievements of staff and faculty who excel in their roles.
A drug currently in clinical trials as a cancer therapy can also stimulate pancreatic beta cells to secrete insulin, revealing a previously unknown mechanism for insulin regulation in Type 2 diabetes, according to a new study by Weill Cornell Medicine investigators.
Resilient “superfruits” could benefit New York growers by diversifying their crops with native berries and appeal to consumers by offering nutritious new fruit choices.
Cornell chemists have developed a technique that allows them to image polymerization catalysis reactions at single-monomer resolution, key in discovering the molecular composition of a synthetic polymer.
After service in the military, Chris Brunkhorst and Caleb Jones sought new outlets to channel their discipline and their commitment to helping others – and they both found it in neuroscience.
Researchers at Weill Cornell Medicine have uncovered a novel route to stimulate the growth of healthy insulin-producing pancreatic beta cells in a preclinical model of diabetes. The findings hold promise for future therapeutics that will improve the lives of individuals with Type 2 diabetes – a condition that affects more than 500 million people worldwide.
A special type of cell, called an osteocyte, may hold the key to some of the mysteries of osteoporosis. A research group led by Karl Lewis, assistant professor of biomedical engineering, is studying osteocytes in unique new ways.
